Gene therapy for heart failure

Annals of Medicine

Volumn 36, Issue SUPPL. 1, 2004, Pages 106-115

  Thompson, Richard B ^a   Rungwerth, Katrin ^a   Koch, Walter J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

adrenergic receptors; Calcium regulation; Gene therapy; Heart failure

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE DERIVATIVE; LIPOSOME; MITOGEN ACTIVATED PROTEIN KINASE P38; NAKED DNA; NORADRENALIN; PARVOVIRUS VECTOR; PROTEIN BCL 2; RNA; VIRUS VECTOR;

ADENOVIRUS; ADRENERGIC SYSTEM; APOPTOSIS; CALCIUM CELL LEVEL; CATHETER; CHEMICAL ANALYSIS; CONFERENCE PAPER; ENZYME INHIBITION; GENE TARGETING; GENE THERAPY; HEART FAILURE; HEART MUSCLE; HERPES SIMPLEX VIRUS; HOMEOSTASIS; HUMAN; METHODOLOGY; NONHUMAN; PERICARDIUM; PLASMID; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROVIRUS;

ANIMALS; CALCIUM; CALCIUM CHANNELS; GENE THERAPY; GENETIC VECTORS; HEART FAILURE, CONGESTIVE; HUMANS; MODELS, BIOLOGICAL; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA;

EID: 2442662687     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/17431380410032652     Document Type: Conference Paper

References (54)

1. Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205.
2. Houser SR, Piacentino V, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 2000;32:1595-607.
3. 2+ transients. Circulation 1997;96:400-3.
4. Koch WJ, Lefkowitz RJ, Rockman HA. Functional consequences of altering myocardial adrenergic receptor signaling. Annu Rev Physiol 2000;62:237-60.
5. Rockman HA, Koch WJ, Lefkowitz RJ. Seven membrane spanning receptors and heart function. Nature 2002;415: 234-9.
6. Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmac Ther 1993;60:405-30.
7. 1-adrenergic receptors in the failing heart. Circulation 1993;87:454-63.
8. 1-receptor down-regulation in heart failure. Circ Res 1986;59:297-309.
9. 2-adrenergic receptor. Science 1994;264:582-6.
10. 2-adrenergic receptor overexpression in mouse hearts: a critical role for expression level. Circulation 2000;101:1707-14.
11. 1-adrenergic receptor transgenic mice. Proc Nat Acad Science USA 1999;96:7059-64.
12. Beuckelmann DJ, Naebaur M, Erdmann E. Intracellular calcium handling in isolated ventricular from myocytes from patients with terminal heart failure. Circulation 1992;85:1046-55.
13. Schmidt U, Hajjar RJ, Helm PA, Kim CS, Doye AA, Gwathmey JK. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J Mol Cell Cardiol 1998;30:1929-37.
14. del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec GW, et al. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 1999;100:2308-11.
15. Hoshijma M, Ikeda Y, Iwanaga Y, Minamisawa S, Date MO, Guy Y, et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 2002;8:864-71.
16. Miyamoto MI, delMonte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 2000;97: 793-8.
17. delMonte F, Williams E, Lebeche D, Schmidt U, Rosenzweig A, Gwathmey JK, et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation 2001;104:1424-9.
18. Baartscher A. Adenovirus gene transfer of SERCA in heart failure. A promising therapeutic approach? Cardiovasc Res 2001;41:249-52.
19. delMonte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ. Targeting phospholamban by gene transfer in human heart failure. Circulation 2002;105:904-7.
20. Hasenfuss G. Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failure. Circ Res 1998;83:966-8.
21. 2-adrenergic receptor to donor hearts enhances cardiac function. Gene Ther 1999;6:1298-304.
22. 2-adrenergic receptor gene delivery. J Clin Invest 1999;104:21-9.
23. 2-adrenergic receptor in the heart: prospects for molecular ventricular assistance. Circulation 101:408-142000.
24. 2-adrenergic receptors potentiate the functional recovery of unloaded failing hearts. Circulation 2002;106:124-9.
25. Kawahira Y, Sawa Y, Nishimura M, Sakakida S, Ueda H, Kaneda Y, et al. In vivo transfer of a β2-adrenergic receptor gene into the pressure- overloaded rat heart enhances cardiac response to beta-adrenergic agonist. Circulation 1998; 98: 11262-67.
26. Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 1999;100:2210-2.
27. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 1995;268:1350-3.
28. Akhter SA, Eckhart AD, Rockman HA, Shotwell KF, Lefkowitz RJ, Koch WJ. In vivo inhibition of elevated myocardial β-adrenergic receptor kinase activity in hybrid transgenic mice restores normal β-adrenergic signaling and function. Circulation 1999;100:648-53.
29. Rockman HA, Chien KR, Choi D-J, Iaccarino G, Hunter JJ, Ross Jr, J, et al. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of heart failure in gene targeted mice. Proc Natl Acad Sci USA 1998;95:7000-5.
30. Freeman K, Olsson MC, Iaccarino G, Bristow MR, Lefkowitz RJ, Kranias EL, et al. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest 2001;107:967-74.
31. Harding V, Jones L, Lefkowitz RJ, Koch WJ, Rockman HA. Cardiac βARK1 inhibition prolongs survival and augments βblocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci USA 2001;98:5809-14.
32. White DC, Hata JA, Shah AS, Glower DD, Lefkowitz RJ, Koch WJ. Preservation of Myocardial β-Adrenergic Receptor Signaling Delays the Development of Heart Failure Following Myocardial Infarction. Proc Natl Acad Sci USA 2000;97:5428-33.
33. Tevaearai HT, Eckhart AD, Shotwell KF, Wilson K, Koch WJ. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a β-adrenergic receptor kinase inhibitor. Circulation 2001;104:2069-74.
34. Shah AS, White DC, Emani S, Kypson AP, Lilly RE, Wilson K, et al. In vivo ventricular gene delivery of a β-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation 2001;103:1311-6.
35. Emani SM, Shah AS, White DC, Glower DD, Koch WJ. Right ventricular gene therapy with a beta-adrenergic receptor kinase inhibitor improves survival after pulmonary artery banding. Ann Thorac Surg 2001;72:1657-61.
36. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirtis vectors. Circ Res 1993;73:1202-7.
37. Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 1993;90:11498-502.
38. Rosengart TK, Lee LY, Patel SR, Kligfield PD, Okin PM, Hackett NR, et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 1999;230:466-70.
39. Fromes Y, Salmon A, Wang X, Collin H, Rouche A, Hagege A, et al. Gene delivery to the myocardium by intrapericardial injection. Gene Ther 1999;4:683-8.
40. Hajjar RJ, Schmidt U, Matsui T, Guerrero JL, Lee KH, Gwathmey JK, et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 1998;95: 5251-6.
41. Davidson MJ, Jones JM, Emani SM, Wilson KH, Jaggers J, Koch WJ, et al. Cardiac gene delivery with cardiopulmonary bypass. Circulation 2001;104:131-3.
42. Bridges CR, Burkman JM, Malekan R, Konig SM, Chen H, Yarnell CB, et al. Global cardiac-specific transgene expression using cardiopulmonary bypass with cardiac isolation. Ann Thorac Surg 2002;73:1929-46.
43. Wright MJ, Wightma LML, Lilley C, de Alwis M, Hart SL, Miller A, et al. In vivo myocardial gene transfer: Optimization, evaluation and direct comparison of gene transfer vectors. Basic Res Cardiol 2000;96:227-36.
44. Walther W, Stein U. Viral vectors for gene transfer - a review of their use in the treatment of human diseases. Drugs 2000; 60:249-71.
45. Leiden JM. Human gene therapy: the good, the bad, and the ugly. Circ Res 2000;86:923-5.
46. Amalfitano A, Parks RJ. Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy. Curr Gene Ther 2002;2:111-33.
47. Asfour B, Baba HA, Scheld HH, Hruban RH, Hammel D, Byrne BJ. Uniform Long-Term Gene Expression using Adeno-Associated Virus (AAV) by Ex Vivo Recirculation in Rat-Cardiac Isografts. Thorac Cardiovasc Surg 2002;50:347-50.
48. Monahan E, Samulski RJ. AAV vectors: is clinical success on the horizon? Gene Ther 2000;7:24-30.
49. Aikawa R, Huggins GS, Snyder RO. Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction. J Biol Chem 2002;277:18979-85.
50. Kim SH, Yu SS, Park JS, Robbins PD, An CS, Kim S. Construction of retroviral vectors with improved safety, gene expression, and versatility. J Virol 1998;72:994-1004.
51. Wang H, Katovich MJ, Gelband CH, Reaves PY, Phillips MI, Raizada MK, et al. Sustained inhibition of Angiotensin I-Converting Enzyme (ACE) expression and long-term antihypertensive action by vitally mediated delivery of ACE antisense cDNA. Circ Res 1999;85:614-22.
52. Krisky DM, Marconi PC, Oligino TJ, Rouse RJ, Fink DJ, Cohen JB, et al. Development of herpes simplex virus replication-Defective multigene vectors for combination gene therapy application. Gene Ther 1998;5:1517-30.
53. Coffin RS, Howard MK, Cumming DV, Dollery CM, McEwan J, Yellow DM, et al. Gene delivery to cardiac cells in vitro and in vivo using herpes simplex virus vectors. Gene Ther 1996;3:560-6.
54. Ledley F. Non-viral gene therapy. Curr Opin Biotechnol 1994; 5:526-36.